Navigation Links
HORIZONS AMI trial data will help set guidelines
Date:10/24/2007

WASHINGTON, DC OCTOBER 24, 2007 Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

Results of the HORIZONS AMI trial, sponsored by the Cardiovascular Research Foundation, were measured at 30 days; the patients will be observed for five years to collect long-term data.

This is a landmark trial, which will help establish the guidelines for drug and stent therapy during primary angioplasty in patients with heart attacks for many years to come, said Gregg W. Stone, MD, Chairman of the Cardiovascular Research Foundation and Professor of Medicine, Columbia University Medical Center.

Usually, angioplasty is associated with an excess of bleeding in heart attack patients, Dr. Stone said. In the first phase of the HORIZONS AMI trial, we sought to determine whether using bivalirudin instead of heparin and glycoprotein IIb/IIIa inhibitors in patients with a heart attack after angioplasty reduces this high rate of bleeding and improves survival, as it does in stable coronary artery disease.

In addition, while previous studies of drug-eluting stents have often focused on their use in patients with stable or unstable chest pain, this is the largest study to focus on the appropriate use of anticoagulation medications and drug-eluting stents in patients experiencing the most dangerous form of heart attack (ST-elevation myocardial infarction).

The HORIZONS AMI trial enrolled over 3600 patients presenting to hospitals in 11 countries with a heart attack. More than 120 national and international interventional cardiology centers are participating in the trial. Patients undergoing angioplasty were random
'/>"/>

Contact: Irma Damhuis
idamhuis@crf.org
917-558-5180
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Male contraceptive in trial
4. How do patients benefit of clinical trials
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Cannabis Network that a company located in Massachusetts has ... the only marijuana patient verification system in ... welcome this new entity to our growing and compassionate ... our belief that these claims are inaccurate. , ...
(Date:8/21/2014)... Steven Reinberg HealthDay Reporter ... experimental drug shows promise in treating respiratory syncytial virus (RSV), ... "We are finally making major progress in being able to ... of serious viral pneumonia, second only to influenza virus," said ... the University of Tennessee College of Medicine in Memphis. ...
(Date:8/21/2014)... do not protest being overcompensated, even when there ... Brains and Behavior Program have found. , This ... previously believed about the inequity of others, researchers ... Brain Connectivity . These findings suggest humans, ... indicating the interest humans show in others, outcomes ...
(Date:8/21/2014)... August 21, 2014 Competing in the ... Metal Greg” will screen on Monday, August 25th at ... International Film Festival. This festival is named in top ... Video Symphony, Sony Software, Avid, and Write Brothers. , ... 12 & LFX, located at 410 South Myrtle Avenue ...
(Date:8/21/2014)... The report "Indoor Location Market by ... Navigation, Location based analytics, Location based services, ... Forecasts and Analysis (2014 - 2019)" defines ... various sub-segments with an in-depth analysis and ... the factors driving this market, various restraints, ...
Breaking Medicine News(10 mins):Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:“Heavy Metal Greg,” a Music Talk Show by Gregory Graham, Will Screen at Action on Film International Film Festival on 08/25/2014 2Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 4
... Carolina-based Oaks,Development Group announced today the company has closed ... Drive behind St. David Medical Center in Austin,Texas. A ... is being converted to Oaks, unique tenant-ownership model., ... purpose limited liability,company (L.L.C.). Tenant partners split ownership interest ...
... Blue Cross and Blue,Shield in Wisconsin announced today ... this year. The changes will include reimbursement,modifications and ... by the Centers for Medicare and Medicaid Services ... will help protect,Anthem,s nearly 1 million members from ...
... As part of the Opening Ceremonies of its 37th ... Anatole Hotel, the American Association for Dental Research (AADR) ... , The AADR Distinguished Scientist Award , ... who has contributed outstanding research of particular significance in ...
... 2008 /Xinhua-PRNewswire-FirstCall/ -- China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: ... is engaged in the research, development, manufacture,and marketing ... People,s Republic of China ("PRC"), today announced that ... & Co. Mainland China,Investor Tour to be held ...
... Global,Health, Inc. (OTC Bulletin Board: FGHH) today stated that ... it provided a 2008,revenue forecast of approximately $6.2 million. ... expects 2008 gross margins of 61 percent., A ... Flagship Global Health,s website, http://www.flagshipglobalhealth.com, no later,than ...
... Maker of Rugged Computers Donates GoBook(R) XR-1 Notebooks to ... Support Zambezi ... General Dynamics,Itronix, an industry leading maker of rugged notebook computers, ... Fighting Malaria on the "River of Life." The XR-1 computers ...
Cached Medicine News:Health News:Oaks Development Group Acquires Medical Office Building in Austin, Texas 2Health News:Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 2Health News:Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 3Health News:AADR to present prestigious awards and recognitions 2Health News:AADR to present prestigious awards and recognitions 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Present at Brean Murray Carret & Co. Mainland China Investor Tour 2Health News:Flagship Global Health Provides 2008 Financial Guidance 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 3
(Date:8/21/2014)... 2014  SI-BONE, Inc. ( San Jose, California ... use of the iFuse Implant System, ® a ... the sacroiliac (SI) joint, announced that Priority Health ( ... Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage ... states that the fusion procedure, which employs the iFuse ...
(Date:8/20/2014)... 20, 2014 Northstar Global Business Services, ... months of hard work from many talented specialists, ... formulation and package design.  The new formulation for ... into the product due to overwhelming evidence of ... Snorenz Nighttime will also include these vitamins, as ...
(Date:8/20/2014)... 20, 2014 The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
... Ultra Micro Shafts For Insertion Through ... For Light-Weight ... ,Curved Shafts For A More Comfortable Approach., ... ,Protective Cap Supplied For Protection Of Jaws ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
Medicine Products: